<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________________
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) or 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Genomica Corporation
-------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Delaware 23-2821818
---------------------------------------- -----------------------
(State of Incorporation or Organization) (I.R.S. Employer
Identification No.)
1745 38th Street, Boulder, Colorado 80301
---------------------------------------- -----------------------
(Address of Principal Executive Offices) (Zip Code)
If this form relates to the If this form relates to the registration
registration of a class of of a class of securities pursuant to
securities pursuant to Section Section 12(g) of the Exchange Act and is
12(b) of the Exchange Act and is effective pursuant to General
effective pursuant to General Instruction A.(d), please check the
Instruction A.(c), please check the following box. [X]
following box. [ ]
Securities Act registration statement file number to which this form
relates: 333-32472
-----------------------
(If applicable)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class Names of Each Exchange on Which
to be so Registered Each Class is to be Registered
-------------------------------- -------------------------------------
None
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, par value $.001 per share
--------------------------------------------------------------------------------
(Title of Class)
<PAGE>
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
A description of the Registrant's Common Stock, par value $.001 per share,
being registered hereby is contained in the Registrant's Registration Statement
on Form S-1, as amended (Registration No. 333-32472) (the "Registration
Statement"), initially filed with the Securities and Exchange Commission on
March 14, 2000, under the caption "Description of Capital Stock" and is
incorporated herein by reference.
ITEM 2. EXHIBITS.
Each of the following exhibits to this registration statement has been
filed as an exhibit to the Registration Statement (as defined above) and is
incorporated herein by reference:
Exhibit
Number Description
------ -----------
1 Restated Certificate of Incorporation, currently in effect.
2 Form of Restated Certificate of Incorporation, to be filed and
become effective upon the closing of the public offering covered by
the Registration Statement.
3 Bylaws, currently in effect.
4 Amended and Restated Bylaws, to become effective upon the closing
of the public offering covered by the Registration Statement.
5 Specimen stock certificate representing shares of Common Stock.
6 Second Amended and Restated Investors' Rights Agreement, dated
September 5, 2000, among the Company and certain stockholders.
7 Warrant Agreement to purchase shares of Series A Preferred Stock
with Silicon Valley Bank, dated September 10, 1997.
1.
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the Registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereunto duly authorized.
GENOMICA CORPORATION
Date: September 26, 2000 By: /s/ Daniel R. Hudspeth
------------------------------------------
Daniel R. Hudspeth
Vice President of Finance, Chief Financial
Officer, Secretary and Treasurer
2.
